Price T Rowe Associates Inc Arcturus Therapeutics Holdings Inc. Transaction History

Price T Rowe Associates Inc

$867 Billion
Q4 2024

A detailed history of Price T Rowe Associates Inc transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 19,018 shares of ARCT stock, worth $343,274. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,018

Previous 17,739 7.21%

Holding current value

$343,274

Previous $412,000 21.6%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$14.82 - $25.48 $18,954 - $32,588	1,279 Added 7.21%	19,018 $323,000
Q3 2024 Nov 14, 2024	BUY	$18.08 - $25.38 $2,205 - $3,096	122 Added 0.69%	17,739 $412,000
Q2 2024 Aug 14, 2024	BUY	$24.35 - $44.39 $14,926 - $27,211	613 Added 3.61%	17,617 $429,000
Q1 2024 May 15, 2024	BUY	$31.23 - $42.99 $28,794 - $39,636	922 Added 5.73%	17,004 $575,000
Q4 2023 Feb 14, 2024	BUY	$17.71 - $32.97 $6,375 - $11,869	360 Added 2.29%	16,082 $508,000
Q3 2023 Nov 14, 2023	SELL	$25.44 - $37.35 $89,930 - $132,032	-3,535 Reduced 18.36%	15,722 $402,000
Q2 2023 Aug 14, 2023	SELL	$23.94 - $32.36 $14,770 - $19,966	-617 Reduced 3.1%	19,257 $553,000
Q1 2023 May 15, 2023	BUY	$14.72 - $23.97 $1,545 - $2,516	105 Added 0.53%	19,874 $477,000
Q4 2022 Feb 14, 2023	BUY	$14.14 - $23.06 $21,521 - $35,097	1,522 Added 8.34%	19,769 $335,000
Q3 2022 Nov 14, 2022	BUY	$13.05 - $22.13 $19,770 - $33,526	1,515 Added 9.05%	18,247 $271,000
Q2 2022 Aug 15, 2022	BUY	$12.26 - $31.17 $5,026 - $12,779	410 Added 2.51%	16,732 $263,000
Q1 2022 May 16, 2022	BUY	$17.64 - $39.57 $22,632 - $50,768	1,283 Added 8.53%	16,322 $440,000
Q4 2021 Feb 14, 2022	BUY	$34.2 - $47.56 $10,191 - $14,172	298 Added 2.02%	15,039 $557,000
Q3 2021 Nov 15, 2021	SELL	$27.88 - $58.25 $3.32 Million - $6.93 Million	-119,000 Reduced 88.98%	14,741 $704,000
Q2 2021 Aug 16, 2021	SELL	$25.79 - $42.11 $1.27 Million - $2.08 Million	-49,328 Reduced 26.95%	133,741 $4.53 Million
Q1 2021 May 17, 2021	SELL	$38.75 - $86.92 $48 Million - $108 Million	-1,239,110 Reduced 87.13%	183,069 $7.56 Million
Q4 2020 Feb 16, 2021	BUY	$34.61 - $123.66 $49.2 Million - $176 Million	1,422,179 New	1,422,179 $61.7 Million

Others Institutions Holding ARCT

# of Institutions

168

Shares Held

26M

Call Options Held

163K

Put Options Held

173K

View Full List

About Arcturus Therapeutics Holdings Inc.

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $480M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

More about ARCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Arcturus Therapeutics Holdings Inc. Transaction History